Stocks to Watch: MiMedx Group, Nokia morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
MiMedx Group said on Friday
the U.S. Food and Drug Administration s warning letter for its
recently launched placental-derived tissue product Axiofill was
not related to safety.
(Reporting by Sriparna.
By Ben Glickman MiMedx Group said on Friday it received an FDA warning letter related to the classification of its product Axiofill. The regulator has.
MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.